Clinical Trial Update: Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an alternative-site goserelin acetate injection for ovarian function suppression in premenopausal hormone receptor-positive br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: Mayo Clinic | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: NOT_YET_RECRUITING